Employees of the Institute of Experimental Neuroregeneration, photo: PMU/Daxenbichler

19. September 2022

New collaboration for vesicle research

“Extracellular Vesicles Therapeutic Technologies” is a flagship project of the Science and Innovation Strategy of the state of Salzburg and is supported by funding from the state of Salzburg and the European Regional Development Fund for investments in growth and employment.

Paracelsus Medical University Salzburg initiates new research collaboration with Boehringer Ingelheim to investigate the natural regenerative potential of extracellular vesicles derived from human stem cells of the supporting tissue. The application of these vesicles will be studied in musculoskeletal or central nervous system disorders.

For over six years, the PMU has been conducting a research program called “Nanovesicular Therapies” in collaboration with university hospitals and the Paris-Lodron University Salzburg. We have previously reported on this.

The director of the Institute of Experimental Neuroregeneration at PMU Salzburg, Sébastien Couillard-Després, views the collaboration with Boehringer Ingelheim as a “visionary cooperation program that enables the development of innovative approaches for treating complex disorders of the central nervous system and musculoskeletal tissue at PMU.”

This might also interest you

12. March 2026

SALZ 2026: Innovation and Technology in Focus – Startups, AI and Future Markets in Salzburg

The SALZ – Festival for Innovation & Technology brought together companies, startups, research institutions and public stakeholders at Messe Salzburg on 11 March 2026. With keynotes, panels, matchmaking and startup pitches, the event provided a platform for emerging technology trends, new collaborations and exchange within the innovation ecosystem.

18. February 2026

SALZ 2026: A Festival for Innovation

How can companies remain competitive, innovative, and resilient in challenging times? SALZ – Festival for Innovation & Technology, together with the startup and investment conference SALT’N’VENTURE, will provide concrete answers on March 11, 2026, at Messezentrum Salzburg, bringing together industry, startups, and investors.

17. February 2026

Life Sciences Center Salzburg Launched

With the Life Sciences Center Salzburg (LSCS), a new inter-university center is being established to strengthen Salzburg as a hub for research and innovation. The federal government and the Province of Salzburg are jointly investing €15 million in its development. It was publicly presented on February 17, 2026, at Unipark Nonntal.

11. November 2025

Eleven Million Euros for Five New Research Centers

Salzburg is investing in research: around eleven million euros from EU and state funds will go toward establishing five new research and transfer centers. They cover key future-oriented topics: artificial intelligence, climate protection, health, tourism, and data security.

Our Newsletter